Michael W. Freeman
Stock Analyst at Raymond James
(2.06)
# 3,333
Out of 4,668 analysts
48
Total ratings
35.3%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Michael W. Freeman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: PRN Profound Medical Corp. | Maintained: Buy | n/a | $9.10 | - | 6 | Aug 7, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Maintained: Buy | n/a | $4.51 | - | 6 | Aug 7, 2026 | |
| TSX: VHI Vitalhub Corp. | Maintained: Buy | n/a | $7.91 | - | 7 | Aug 7, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $36.00 | $33.39 | +7.82% | 1 | Jul 6, 2026 | |
| TSX: AIDX Healwell AI Inc. | Maintained: Buy | $3.00 → $2.50 | $0.77 | +224.68% | 5 | Mar 25, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Maintained: Buy | $6.00 → $7.00 | $3.94 | +77.66% | 2 | Nov 18, 2025 | |
| TSX: MDP Medexus Pharmaceuticals Inc. | Maintained: Buy | $8.00 | $5.01 | n/a | 9 | Aug 14, 2025 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $11.02 | $9.41 | n/a | 7 | Aug 5, 2025 | |
| NGEN NervGen Pharma | Maintained: Buy | $3.27 → $4.36 | $1.76 | n/a | 3 | Jun 11, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.00 | $9.63 | n/a | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1.50 | $0.36 | n/a | 1 | Nov 18, 2024 |
Profound Medical Corp.
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $9.10
Upside: -
WELL Health Technologies Corp.
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $4.51
Upside: -
Vitalhub Corp.
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $7.91
Upside: -
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $36.00
Current: $33.39
Upside: +7.82%
Healwell AI Inc.
Mar 25, 2026
Maintained: Buy
Price Target: $3.00 → $2.50
Current: $0.77
Upside: +224.68%
HLS Therapeutics Inc.
Nov 18, 2025
Maintained: Buy
Price Target: $6.00 → $7.00
Current: $3.94
Upside: +77.66%
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Maintained: Buy
Price Target: $8.00
Current: $5.01
Upside: n/a
Bausch Health Companies Inc.
Aug 5, 2025
Maintained: Hold
Price Target: $11.02
Current: $9.41
Upside: n/a
NervGen Pharma
Jun 11, 2025
Maintained: Buy
Price Target: $3.27 → $4.36
Current: $1.76
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Maintained: Buy
Price Target: $8.00
Current: $9.63
Upside: n/a
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.36
Upside: n/a